Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com

Copyright 2025 Pharma-Marketing.com.
All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year

Unfair Competition Law - Protection and compliance in pharmaceutical marketing

Contents

  1. What does Germany's UWG regulate?
  2. How are statements and comparisons assessed?
  3. Which rules apply to direct marketing?
  4. What matters in digital campaigns?
  5. Conclusion: Plan fair communication transparently

What does Germany's UWG regulate?

Germany's Unfair Competition Act, or Gesetz gegen den unlauteren Wettbewerb (UWG), protects consumers, competitors and other market participants against unfair commercial practices. It addresses misleading statements, aggressive influence, comparative advertising and unwanted direct marketing.

Pharmaceutical and healthcare companies must observe the UWG alongside product-specific rules. A campaign may therefore need assessment under both the Drug Advertising Act and competition law. Internal approval or agreement with a media partner does not replace that assessment.

How are statements and comparisons assessed?

The overall impression of a commercial communication matters. Important qualifications must not be hidden in a way that creates a misleading message. Examples include claimed benefits, study findings, availability and presentation of commercial interests.

Comparative advertising under section 6 UWG requires, among other conditions, an objective comparison of material, relevant, verifiable and representative features or price. Medicines may face additional HWG restrictions. A comparison table is not automatically lawful because its tone appears factual.

Which rules apply to direct marketing?

Email advertising generally requires prior express consent. Section 7 UWG provides a narrow existing-customer exception with several cumulative conditions. A publicly listed professional address or previous webinar attendance alone does not establish that exception.

For telephone advertising, the law distinguishes consumers from other market participants. Presumed consent can be relevant for the latter, but the caller's commercial interest is not a blanket justification. Privacy and professional requirements must also be considered.

What matters in digital campaigns?

Commercial partnerships need to be recognizable. Reviews and recommendations must not be fabricated or misleadingly presented. Forms and campaigns should align consent wording, sender identity, purpose and an easy way to end communications.

A practical review process records the claim, supporting evidence, intended recipients and channel. Later content changes need assessment to determine whether the earlier approval still applies. Reach metrics do not replace substantive review.

Conclusion: Plan fair communication transparently

The UWG limits how businesses address their audiences. Breaches may particularly lead to warning letters and injunctions; other consequences depend on the provision involved. Supportable claims, recognizable advertising and permitted contact channels provide a sound basis for communication planning.

Related topics

  • German Drug Advertising Act (HWG)

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • 8awake
  • MINTT Digital
  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

  • MINTT Digital

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder